{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:06:08Z","timestamp":1756512368082,"version":"3.44.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,29]]},"DOI":"10.7759\/cureus.91241","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:41:54Z","timestamp":1756482114000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis and Treatment of Augmentation Syndrome Secondary to Ropinirole: A Case Report"],"prefix":"10.7759","author":[{"given":"Rey  D","family":"Nuez Lopez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casilda","family":"Balmaceda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1160112","article-title":"Exploring the causes of augmentation in restless legs syndrome","volume":"14","author":"Zeng P","year":"2023","unstructured":"Zeng P, Wang T, Zhang L, Guo F. Exploring the causes of augmentation in restless legs syndrome. Front Neurol. 2023, 14:1160112. 10.3389\/fneur.2023.1160112","journal-title":"Front Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.14.04113","article-title":"The global and regional prevalence of restless legs syndrome among adults: a systematic review and modelling analysis","volume":"14","author":"Song P","year":"2024","unstructured":"Song P, Wu J, Cao J, et al.. The global and regional prevalence of restless legs syndrome among adults: a systematic review and modelling analysis. J Glob Health. 2024, 14:04113. 10.7189\/jogh.14.04113","journal-title":"J Glob Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2174\/1874205X01509010004","article-title":"Augmentation in restless legs syndrome: Treatment with gradual medication modification","volume":"9","author":"Rosenstein A","year":"2015","unstructured":"Rosenstein A, Rabin M, Kurlan R. Augmentation in restless legs syndrome: Treatment with gradual medication modification. Open Neurol J. 2015, 9:4-6. 10.2174\/1874205X01509010004","journal-title":"Open Neurol J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15221","article-title":"Factors associated with augmentation in patients with restless legs syndrome","volume":"29","author":"Heim B","year":"2022","unstructured":"Heim B, Ellmerer P, Stefani A, et al.. Factors associated with augmentation in patients with restless legs syndrome. Eur J Neurol. 2022, 29:1227-31. 10.1111\/ene.15221","journal-title":"Eur J Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2023.10.022","article-title":"Association of low serum ferritin levels with augmentation in patients with restless legs syndrome: a systematic review and meta-analysis","volume":"112","author":"Li YS","year":"2023","unstructured":"Li YS, Yeh WC, Hsu CY. Association of low serum ferritin levels with augmentation in patients with restless legs syndrome: a systematic review and meta-analysis. Sleep Med. 2023, 112:173-80. 10.1016\/j.sleep.2023.10.022","journal-title":"Sleep Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.12740\/PP\/35395","article-title":"Frequent difficulties in the treatment of restless legs syndrome - case report and literature review","volume":"49","author":"Narowska D","year":"2015","unstructured":"Narowska D, Bo\u017cek M, Krysiak K, Antczak J, Holka-Pokorska J, Jernajczyk W, Wichniak A. Frequent difficulties in the treatment of restless legs syndrome - case report and literature review. Psychiatr Pol. 2015, 49:921-30. 10.12740\/PP\/35395","journal-title":"Psychiatr Pol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2016.01.017","article-title":"Guidelines for the first-line treatment of restless legs syndrome\/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation","volume":"21","author":"Garcia-Borreguero D","year":"2016","unstructured":"Garcia-Borreguero D, Silber MH, Winkelman JW, et al.. Guidelines for the first-line treatment of restless legs syndrome\/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Sleep Med. 2016, 21:1-11. 10.1016\/j.sleep.2016.01.017","journal-title":"Sleep Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-015-0250-2","article-title":"Long-term treatment of restless legs syndrome (RLS): an approach to management of worsening symptoms, loss of efficacy, and augmentation","volume":"29","author":"Mackie S","year":"2015","unstructured":"Mackie S, Winkelman JW. Long-term treatment of restless legs syndrome (RLS): an approach to management of worsening symptoms, loss of efficacy, and augmentation. CNS Drugs. 2015, 29:351-7. 10.1007\/s40263-015-0250-2","journal-title":"CNS Drugs"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21610","article-title":"Augmentation as a treatment complication of restless legs syndrome: concept and management","volume":"22","author":"Garc\u00eda-Borreguero D","year":"2007","unstructured":"Garc\u00eda-Borreguero D, Allen RP, Benes H, et al.. Augmentation as a treatment complication of restless legs syndrome: concept and management. Mov Disord. 2007, 22:S476-84. 10.1002\/mds.21610","journal-title":"Mov Disord"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2007.03.022","article-title":"Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute","volume":"8","author":"Garc\u00eda-Borreguero D","year":"2007","unstructured":"Garc\u00eda-Borreguero D, Allen RP, Kohnen R, et al.. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med. 2007, 8:520-30. 10.1016\/j.sleep.2007.03.022","journal-title":"Sleep Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2012-131634","article-title":"Restless legs syndrome: pathophysiology and modern management","volume":"89","author":"Nagandla K","year":"2013","unstructured":"Nagandla K, De S. Restless legs syndrome: pathophysiology and modern management. Postgrad Med J. 2013, 89:402-10. 10.1136\/postgradmedj-2012-131634","journal-title":"Postgrad Med J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2009.11.006","article-title":"Dopaminergic augmentation of restless legs syndrome","volume":"14","author":"Garc\u00eda-Borreguero D","year":"2010","unstructured":"Garc\u00eda-Borreguero D, Williams AM. Dopaminergic augmentation of restless legs syndrome. Sleep Med Rev. 2010, 14:339-46. 10.1016\/j.smrv.2009.11.006","journal-title":"Sleep Med Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/294257-diagnosis-and-treatment-of-augmentation-syndrome-secondary-to-ropinirole-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:41:55Z","timestamp":1756482115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/294257-diagnosis-and-treatment-of-augmentation-syndrome-secondary-to-ropinirole-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.91241","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,29]]}}}